This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

People living with chronic kidney disease (CKD) often experience multimorbidity and require
polypharmacy. Kidney dysfunction can also alter the pharmacokinetics and …

Current Opinion in Nephrology and Hypertension Log in or Register Subscribe to journalSubscribe
Get new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle …

Results In total, 47 patients (26 men; mean age= 59 years old; 33% were≥ 65 years old)
were enrolled; 60% had never used a smartphone. User adherence was high (> 80 …

Background Elderly patients with chronic kidney disease (CKD) frequently present
comorbidities that put them at risk of polypharmacy and medication-related problems. This …

Polypharmacy is a common problem among hemodialysis patients. It is associated with
increased hospital admissions, morbidity, mortality, Medication-Related Problems (MRPs) …

Patients with ESRD undergoing dialysis have highly complex medication regimens and
disproportionately higher total cost of care compared with the general Medicare population …

Background Due to the toxicity issues of synthetic compounds, herbal medicines are
preferred in treating or curing many diseases in recent times. Because of limited treatment …

In clinical practice, multiple drugs are often combined in the treatment of patients with
chronic diseases. These associations generally produce drug interactions (DI) with expected …

Introduction The universal increase in obesity and diabetes has increased the chronic
kidney disease (CKD) rate. In 2017, almost 800 million individuals suffered from CKD …